Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, melanoma
Stage/Subtype:  stage II melanoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-9 of 9 for your search:
Start Over
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: 103A-301, NCI-2012-01351, NCT01546571
BRIM8: A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO27826, NCI-2012-03085, 2011-004011-24, G027826, NCT01667419
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: 10-000062, NCI-2013-00645, 11-002177, NCT01826864
Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 90
Trial IDs: MEL-1263, NCI-2012-01699, 2011N129968_00, VICC MEL 1263, NCT01701037
CDX-1401 and Poly-ICLC Vaccine Therapy with or without CDX-301in Treating Patients with Stage IIB-IV Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-07-FLT3L, NCI-2014-00898, NCT02129075
Recombinant Interferon Alfa-2b or PEG-Interferon Alfa-2b in Treating Patients With Melanoma Undergoing Sentinel Lymph Node Biopsy
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 08-067, NCI-2011-02485, NCT00871533
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Ipilimumab and Radiation Therapy in Treating Patients with High-Risk of Recurrence or Locally Advanced Melanoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00045042, NCI-2014-00258, BMS 184-234, NCT01996202
MART-1 Antigen with or without TLR4 Agonist GLA-SE in Treating Patients with Stage II-IV Melanoma That Has Been Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1177, NCI-2014-02479, Mod14-002307-06, NCT02320305
Start Over